Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2025-12-25 @ 5:17 PM
Study NCT ID:
NCT00060203
Status:
COMPLETED
Last Update Posted:
2014-01-16
First Post:
2003-05-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma
Sponsor:
Case Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-12
Start Date Type:
None
Primary Completion Date:
2003-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-04
Completion Date Type:
ACTUAL
First Submit Date:
2003-05-06
First Submit QC Date:
None
Study First Post Date:
2003-05-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-01-14
Last Update Post Date:
2014-01-16
Last Update Post Date Type:
ESTIMATED